Phase I study of ACE-041, a novel inhibitor of ALK1-mediated angiogenesis, in patients with advanced solid tumors

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2011
This article has no abstract
Epistemonikos ID: d7ab300c49481edf1c8e6e306a01ab5658a1f988
First added on: Feb 04, 2025